DE60027034D1 - 1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung - Google Patents

1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung

Info

Publication number
DE60027034D1
DE60027034D1 DE60027034T DE60027034T DE60027034D1 DE 60027034 D1 DE60027034 D1 DE 60027034D1 DE 60027034 T DE60027034 T DE 60027034T DE 60027034 T DE60027034 T DE 60027034T DE 60027034 D1 DE60027034 D1 DE 60027034D1
Authority
DE
Germany
Prior art keywords
substituents
group optionally
hydrocarbon group
prostatism
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60027034T
Other languages
English (en)
Other versions
DE60027034T2 (de
Inventor
Akihiro Tasaka
Tomohiro Kaku
Masami Kusaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of DE60027034D1 publication Critical patent/DE60027034D1/de
Application granted granted Critical
Publication of DE60027034T2 publication Critical patent/DE60027034T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE60027034T 1999-10-22 2000-10-19 1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung Expired - Lifetime DE60027034T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30156299 1999-10-22
JP30156299 1999-10-22
PCT/JP2000/007284 WO2001030764A1 (fr) 1999-10-22 2000-10-19 Alcools de phenyl-1-(1h-imidazol-4-yl) substitues en position 1, procede de preparation et utilisation de ces derniers

Publications (2)

Publication Number Publication Date
DE60027034D1 true DE60027034D1 (de) 2006-05-18
DE60027034T2 DE60027034T2 (de) 2006-11-09

Family

ID=17898444

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60027034T Expired - Lifetime DE60027034T2 (de) 1999-10-22 2000-10-19 1-substituierte-phenyl-1-(1h-imidazol-4-yl)alkohole, verfahren zu deren herstellung sowie deren verwendung

Country Status (7)

Country Link
US (1) US6518257B1 (de)
EP (1) EP1227086B1 (de)
AT (1) ATE321552T1 (de)
AU (1) AU7950100A (de)
CA (1) CA2388508A1 (de)
DE (1) DE60027034T2 (de)
WO (1) WO2001030764A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960586B2 (en) * 2000-11-20 2005-11-01 Takeda Pharmaceutical Company Limited Imidazole derivatives, process for their preparation and their use
ATE440096T1 (de) 2000-12-08 2009-09-15 Takeda Pharmaceutical Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung
DE60239207D1 (de) * 2001-08-10 2011-03-31 Takeda Pharmaceutical Gnrh-agonistische kombinationsmittel
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
WO2007005668A2 (en) * 2005-06-30 2007-01-11 Amgen Inc. Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
JP5350217B2 (ja) 2006-03-29 2013-11-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ジアリールチオヒダントイン化合物
UY31432A1 (es) 2007-10-26 2009-05-29 Compuestos de diarilhidantoina
EP2222639A1 (de) * 2007-11-21 2010-09-01 Decode Genetics EHF Biaryle als pde4-inhibitoren zur behandlung von lungen- und herz-kreislauf-erkrankungen
AU2008326381B2 (en) * 2007-11-21 2014-10-23 Decode Genetics Ehf Biaryl PDE4 inhibitors for treating inflammation
WO2010059838A2 (en) * 2008-11-20 2010-05-27 Decode Genetics Ehf Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects
TWI640519B (zh) * 2011-11-29 2018-11-11 泰緯生命科技股份有限公司 Ｈｅｃ１活性調控因子及其調節方法
ES2709195T3 (es) 2013-02-28 2019-04-15 Tiumbio Co Ltd Compuesto tricíclico y uso del mismo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
WO1995004723A1 (fr) 1993-08-04 1995-02-16 Yamanouchi Pharmaceutical Co., Ltd. Derive d'imidazolylalkylamine et composition pharmaceutique contenant ledit derive
HUT75871A (en) 1993-09-30 1997-05-28 Yamanouchi Co Azole derivatives and pharmaceutical compositions thereof
EP0820989A4 (de) 1995-03-01 1998-05-06 Yamanouchi Pharma Co Ltd Imidazolderivate und medizinische zubereitungen davon
JP2000504024A (ja) * 1996-04-03 2000-04-04 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質トランスフェラーゼ阻害剤
CN1117732C (zh) 1997-10-02 2003-08-13 第一制药株式会社 新型二氢萘化合物及其制备方法
ATE293102T1 (de) * 1998-04-23 2005-04-15 Takeda Pharmaceutical Naphthalene derivate ,ihre herstellung und verwendung

Also Published As

Publication number Publication date
EP1227086A1 (de) 2002-07-31
WO2001030764A1 (fr) 2001-05-03
ATE321552T1 (de) 2006-04-15
EP1227086A4 (de) 2002-10-28
US6518257B1 (en) 2003-02-11
CA2388508A1 (en) 2001-05-03
DE60027034T2 (de) 2006-11-09
EP1227086B1 (de) 2006-03-29
AU7950100A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
ATE440096T1 (de) Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung
WO2009077874A3 (en) A pharmaceutical composition for treating esophageal cancer
BR9909961A (pt) Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase
ATE321552T1 (de) 1-substituierte-phenyl-1-(1h-imidazol-4- yl)alkohole, verfahren zu deren herstellung sowie deren verwendung
ATE293102T1 (de) Naphthalene derivate ,ihre herstellung und verwendung
DE69923300D1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
PT99134A (pt) Processo para a preparacao de derivados da piperazina
ATE524432T1 (de) Aminverbindung und deren verwendung für medizinische zwecke
UA41869C2 (uk) Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування
WO2003082861A3 (en) Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
DE69521687D1 (de) 4-indol-1-yl-buttersäure derivate, deren herstellung und deren verwendung als inhibitoren für alpha1-adrenerge rezeptoren und testosteron 5alpha-reduktasen
DE3867899D1 (de) Verfahren zur herstellung von 4-amino-androstendion-derivaten.
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
ATE502030T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
HUP9900748A1 (hu) Pirrolidinszármazékok alkalmazása alkoholizmus kezelésére alkalmas gyógyszerkészítmények előállítására
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
ATE449780T1 (de) Derivate von ä2-(8,9-dioxo-2,6- diazabicycloä5.2.0ünon-1(7)-en-2- yl)alkylüphosphonsäure und verfahren zu deren herstellung
ATE249459T1 (de) N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
HUP0102350A2 (hu) Propenil-cefalosporin-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
DE69609498D1 (de) Beta-methoxyacrylsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als pestizide
ATE420067T1 (de) Peptid-derivate und ihre pharmazeutisch akzeptablensalze, verfahren zur herstellung von beiden und ihre verwendung
KR870011096A (ko) 니코틴산 유도체를 함유하는 살진균 조성물, 신규의 니코틴산 유도체 및 그의 제조방법
ATE233266T1 (de) 8h-(2,3-b)-pyrrolozin-8-one derivate, verfahren zur ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition